Picture of Neximmune logo

NEXI — Neximmune News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Neximmune Inc reports results for the quarter ended in June - Earnings Summary

* Neximmune Inc  NEXI.OQ  reported a quarterly adjusted loss
of 29
cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 29 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Neximmune Inc's reported EPS for the quarter was a loss
of 29
cents​.
    * The mean earnings estimate of analysts had risen by
about 20.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Neximmune Inc shares had fallen by 6.0% this quarter and
gained 9.0% so far this year.
    * The company reported a quarterly loss of $7.57 million.
    * Wall Street's median 12-month price target for Neximmune
Inc is
$2.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 12:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.29          -0.29          Met
 Mar. 31 2023      -0.46          -0.37          Beat
 Dec. 31 2022      -0.51          -0.70          Missed
 Sep. 30 2022      -0.69          -0.60          Beat

Recent news on Neximmune

See all news